FrancophonIA/ELRC3.0 huggingface dataset:
English: DAA-experienced adults who had not received an NS5A inhibitor (POLARIS-4) Table 11 presents the SVR12 by HCV genotype and virologic outcome for the POLARIS-4 trial.
Maltese: It-Tabella 11 tippreżenta l-SVR12 skont il-ġenotip tal-HCV u r-riżultat viroloġiku għall-prova POLARIS-4.
English: Patients with GT1-3 infection were randomised in a 1:1 ratio to SOF/VEL/VOX or SOF/VEL for 12 weeks.
Maltese: Pazjenti b'infezzjoni GT1-3 kienu magħżula b'mod każwali fi proporzjon ta' 1:1 għal SOF/VEL/VOX jew SOF/VEL għal 12-il ġimgħa.
English: No patients in the placebo group achieved SVR4.
Maltese: L-ebda pazjent fil-grupp tal-plaċebo ma kiseb SVR4.
English: 1.6-fold↑ 2.1-fold↑ 2.7-fold↑ 1.3-fold↑ 1.6-fold↑ ~2-fold↑ 1.8-fold↑ GS-331007 1.6-fold↑ 1.9-fold↑ 5.5-fold↑ ≥10-fold↑ ≥20-fold↑ ~7-fold↑ 18-fold↑
Maltese: [VEL]/voxilaprevir [VOX]) kienet evalwata f'erba' studji tal-Fażi 3, żewġ studji f'pazjenti li rċivew DAA fil-passat u żewġ studji f'pazjenti li qatt ma rċivew DAA fil-passat, b'infezzjoni bl-HCV ta' ġenotip 1 sa 6 mingħajr ċirrożi jew b'ċirrożi kumpensata, kif muri fil-qosor fit-Tabella 8.
English: Atorvastatin may be administered with Vosevi at a dose that does not exceed atorvastatin 20 mg.
Maltese: Atorvastatin jista' jingħata ma' Vosevi b'doża li ma taqbiżx atorvastatin 20 mg.
English: The proportion of patients who permanently discontinued treatment due to adverse reactions was 0.1% for patients receiving sofosbuvir/velpatasvir/voxilaprevir for 8 weeks.
Maltese: Il-proporzjon ta' pazjenti li waqfu jieħdu l-kura b'mod permanenti minħabba reazzjonijiet avversi kien ta' 0.1% għal pazjenti li ngħataw sofosbuvir/velpatasvir/voxilaprevir għal 8 ġimgħat.
English: No dose adjustment of Vosevi or emtricitabine/rilpivirine/tenofovi r alafenamide is required.
Maltese: Mhux meħtieġ aġġustament fid-doża ta' Vosevi jew emtricitabine/rilpivirine/tenof ovir alafenamide.
English: • atorvastatin, pravastatin, or other statins, used to treat high cholesterol;
Maltese: • atorvastatin, pravastatin, jew statins oħra, użati biex jikkuraw il-kolesterol għoli;
English: • If you are sick (vomit) less than 4 hours after taking Vosevi, take another tablet.
Maltese: • Jekk tirremetti inqas minn 4 sigħat wara li tkun ħadt Vosevi, ħu pillola oħra.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines webportal.
Maltese: Ir-rekwiżiti biex jiġu ppreżentati rapporti perjodiċi aġġornati dwar is-sigurtà għal dan il-prodott mediċinali huma mniżżla fil-lista tad-dati ta 'referenza tal-Unjoni (lista EURD) prevista skont lArtikolu 107c(7) tad-Direttiva 2001/83/KE u kwalunkwe aġġornament sussegwenti ppubblikat fuq il-portal elettroniku Ewropew tal-mediċini.
English: Uncommon muscle spasm Laboratory investigations: Common total bilirubin increased
Maltese: Komuni żieda fil-bilirubina totali
English: IMMUNOSUPPRESSANTS
Maltese: KONTRAĊETTIVI ORALI
English: Velpatasvir was not carcinogenic in the 26-week transgenic mouse and 2-year rat carcinogenicity studies at exposures up to 67- and 5-times higher than human exposure, respectively.
Maltese: Velpatasvir ma kienx karċinoġeniku fl-istudji dwar karċinoġeniċità li damu għaddejjin 26 ġimgħa fuq il-ġrieden transġeniċi u sentejn fuq il-firien b'esponimenti sa 67 darba u 5 darbiet ogħla millesponiment tal-bniedem, rispettivament.
English: California poppy EMA/HMPC/334023/2015
Maltese: Ħaxixa tal-peprin ta' Kalifornja EMA/HMPC/334023/2015
English: For detailed information on the studies assessed by the HMPC, see the HMPC assessment report.
Maltese: Dit is een vertaling van de samenvatting voor het publiek van het oorspronkelijke HMPC beoordelingsrapport dat in het engels is aangemaakt door het EMA secretariaat.
English: California poppy is the common name for the above-ground parts of the plant Eschscholzia californica Cham.
Maltese: Il-ħaxixa tal-peprin ta' Kalifornja hija l-isem komuni għall-partijiet ta' fuq l-art tal-pjanta Eschscholzia californica Cham.
English: What are the risks associated with California poppy medicines?
Maltese: X'inhuma r-riskji assoċjati mal-mediċini tal-ħaxixa tal-peprin ta' Kalifornja?
English: How are California poppy medicines approved in the EU?
Maltese: Kif jiġu approvati fl-UE l-mediċini tal-ħaxixa tal-peprin ta' Kalifornja?
English: Further information on the risks associated with California poppy medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: Aktar informazzjoni dwar ir-riskji assoċjati mal-mediċini tal-ħaxixa tal-peprin ta' Kalifornja, inklużi lprekawzjonijiet xierqa għall-użu sigur tagħhom, tinsab fil-monografu taħt it-tab "Id-dokumenti kollha" fis-sit elettroniku tal-Aġenzija:
English: Further information on the HMPC assessment of California poppy medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Herbal medicines containing California poppy are usually available in solid forms to be taken by mouth.
Maltese: Mediċini erbali li fihom il-ħaxixa tal-peprin ta' Kalifornja normalment huma disponibbli f'forom solidi sabiex jittieħdu mill-ħalq.
English: In its assessment, the HMPC also considered a few available clinical studies, including a study in patients suffering from sleep disorders, which suggested a positive effect on sleep.
Maltese: Fil-valutazzjoni tiegħu, l-HMPC ikkunsidra wkoll xi studji kliniċi disponibbli, inkluż studju f'pazjenti li jbatu minn disturbi tal-irqad, li ssuġġerixxa effett pożittiv fuq l-irqad.
English: The HMPC conclusions on the use of California poppy medicines to relieve mild symptoms of mental stress and to aid sleep are based on their ‘traditional use'.
Maltese: Il-konklużjonijiet tal-HMPC dwar l-użu ta' mediċini tal-ħaxixa tal-peprin ta' Kalifornja għas-solliev minn sintomi ħfief ta' stress mentali u biex jgħinu fl-irqad huma bbażati fuq l-"użu tradizzjonali" tagħhom.
English: California poppy
Maltese: Ħaxixa tal-peprin ta' Kalifornja
English: California poppy preparations should only be used in adults.
Maltese: Il-preparazzjonijiet tal-ħaxixa tal-peprin ta' Kalifornja għandhom jintużaw biss fl-adulti.
English: Any applications for the licensing of medicines containing California poppy have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Maltese: Kwalunkwe applikazzjoni għal-liċenzjar ta' mediċini li fihom il-ħaxixa tal-peprin ta' Kalifornja għandha titressaq lill-awtoritajiet nazzjonali responsabbli mill-prodotti mediċinali li ser jivvalutaw l-applikazzjoni għall-mediċina erbali u jqisu l-konklużjonijiet xjentifiċi tal-HMPC.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of California poppy.
Maltese: Dan huwa sommarju tal-konklużjonijiet xjentifiċi li wasal għalihom il-Kumitat għall-Prodotti Mediċinali Erbali (HMPC) dwar l-użi mediċinali tal-ħaxixa tal-peprin ta' Kalifornja.
English: Further information on Epidyolex can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/epidyolex.
Maltese: ema.europa.eu/medicines/human/EPAR/epidyolex.
English: Further information on the orphan designations can be found on the European Medicines Agency's website: (Dravet syndrome: 15 October 2014; Lennox-Gastaut syndrome: 20 March 2017).
Maltese: Aktar informazzjoni dwar id-denominazzjonijiet orfni tista' tinstab fuq is-sit web talAġenzija Ewropea għall-Mediċini: (Sindrome ta' Dravet: 15 ta' Ottubru 2014; sindrome ta' LennoxGastaut 20 ta' Marzu 2017).
English: Epidyolex (cannabidiol)
Maltese: Epidyolex (kannabidjol)
English: Other information about Epidyolex
Maltese: Informazzjoni oħra dwar Epidyolex
English: The recommended starting dose is 2.5 mg per kilogram body weight given twice a day.
Maltese: Id-doża rrakkomandata tal-bidu hija 2.5 mg għal kull kilogramm tal-piż tal-ġisem, li tingħata darbtejn kuljum.
English: Epidyolex contains the active substance cannabidiol.
Maltese: Epidyolex fih is-sustanza attiva kannabidjol.
English: Symptoms include multiple types of seizure (fits), abnormal electrical activity in the brain, learning disability and behavioural problems.
Maltese: Is-sintomi jinkludu tipi multipli ta' attakki epilettiċi (aċċessjonijiet), attività elettrika anormali fil-moħħ, diżabbiltà fit-tagħlim u problemi fl-imġiba.
English: In the two other studies in patients with Dravet syndrome, the reduction in the number of convulsive seizures (major fits with loss of consciousness) was up to 61% for patients taking Epidyolex and clobazam, and up to 38% for patients on placebo and clobazam.
Maltese: Fiż-żewġ studji l-oħra f'pazjenti b'sindrome ta' Dravet, it-tnaqqis fl-għadd ta' attakki ta' konvulżjoni (attakki kbar li jħallu l-persuna mhux daqshekk f'sensiha) kien sa 61 % għall-pazjenti li kienu qed jieħdu Epidolex u clobazam, u sa 38 % għall-pazjenti fuq il-plaċebo u l-clobazam.
English: The most common side effects with Epidyolex (which may affect more than 1 in 10 people) are somnolence (sleepiness), decreased appetite, diarrhoea, fever, tiredness and vomiting.
Maltese: L-effetti sekondarji l-aktar komuni ta' Epidyolex (li jistgħu jaffettwaw aktar minn persuna 1 minn kull 10) huma sonnolenza (ngħas) nuqqas ta' aptit, dijarea, deni, għeja u rimettar.
English: In the first two studies, patients with Lennox-Gastaut syndrome taking Epidyolex in combination with clobazam had a reduction of up to 64% in the number of drop seizures (brief loss of muscle tone and reduced consciousness, causing abrupt falls), compared with a reduction of up to 31% for patients given placebo (a dummy treatment) with clobazam.
Maltese: Fl-ewwel żewġ studji, pazjenti bis-sindrome ta' Lennox-Gastaut li kienu qed jieħdu Epidyolex flimkien ma' clobazam kellhom tnaqqis ta' mhux aktar minn 64 % fl-għadd ta' attakki epilettiċi li jwasslu għal waqgħat (telf ta' ton muskolari u meta persuna ma tibqax daqshekk f'sensiha għal perjodu qasir, u dan iwassal għal tnaqqis f'daqqa), meta mqabbla ma' tnaqqis ta' mhux aktar minn 31 % għall-pazjenti li ngħataw plaċebo (kura finta) bi clobazam.
English: After one week, the dose should be increased to a maintenance dose of 5 mg/kg twice a day.
Maltese: Wara ġimgħa, id-doża tista' tiżdied għal doża ta' manteniment ta' 5 mg/kg darbtejn kuljum.
English: Epidyolex is a medicine used in addition to clobazam, another epilepsy medicine, to treat patients from the age of two years who have Lennox-Gastaut syndrome or Dravet syndrome, rare types of epilepsy that begin in childhood and can continue into adulthood.
Maltese: Epidyolex hija mediċina li tintuża flimkien ma' clobazam, mediċina oħra tal-epilessija, għall-kura ta' pazjenti mill-età ta' sentejn li għandhom is-sindrome ta' Lennox-Gastaut jew is-sindrome ta' Dravet, tipi rari ta' epilessija li jibdew fit-tfulija u li jistgħu jkomplu f'età adulta.
English: What are the risks associated with Epidyolex?
Maltese: X'inhuma r-riskji assoċjati ma' Epidyolex?
English: As for all medicines, data on the use of Epidyolex are continuously monitored.
Maltese: Bħal fil-każ tal-mediċini kollha, id-data dwar l-użu ta' Epidyolex hija ssorveljata kontinwament.
English: These conditions are rare, and Epidyolex was designated an ‘orphan medicine' (a medicine used in rare diseases).
Maltese: Dawn il-kundizzjonijiet huma rari, u Epidyolex ġie denominat bħala ‘mediċina orfni' (mediċina li tintuża f'mard rari).
English: Epidyolex is available as a liquid containing 100 mg cannabidiol per ml.
Maltese: Epidyolex jiġi bħala likwidu li jkun fih 100 mg kannabidjol għal kull ml.
English: How is Epidyolex used?
Maltese: Epidyolex?
English: Epidyolex must not be used in patients whose blood levels of liver enzymes are more than three times the normal limit and who also have levels of bilirubin (another marker of liver problems) more than twice the normal limit.
Maltese: Epidyolex m'għandux jintuża f'pazjenti li l-livelli ta' enzimi tal-fwied fid-demm tagħhom huma aktar minn tliet darbiet il-limitu normali u li għandhom ukoll livelli ta' bilirubina (markatur ieħor ta' problemi fil-fwied) aktar mid-doppju tal-limitu normali.
English: Regarding safety, treatment with Epidyolex is associated with an increased risk of liver problems.
Maltese: Fir-rigward tassikurezza, il-kura b'Epidyolex hija assoċjata ma' żieda fir-riskju ta' problemi fil-fwied.
English: Cannabidiol is also thought to act on adenosine, a chemical messenger in the brain that plays an important role in suppressing seizures.
Maltese: Il-kannabidjol hija maħsuba wkoll li taġixxi fuq adenożina, messaġġier kimiku fil-moħħ li għandu rwol importanti fit-trażżin ta' attakki epilettiċi.
English: Side effects reported with Epidyolex are carefully evaluated and any necessary action taken to protect patients.
Maltese: L-effetti sekondarji rrappurtati b'Epidyolex huma evalwati bir-reqqa u kull azzjoni meħtieġa hi meħuda biex tipproteġi lill-pazjenti.
English: For the full list of side effects of Epidyolex, see the package leaflet.
Maltese: Aktar informazzjoni dwar Epidyolex tinstab fis-sit web tal-Aġenzija:
English: This risk can be managed with restrictions and regular liver monitoring and is considered acceptable given the seriousness of the conditions and the lack of treatments.
Maltese: Dan ir-riskju jista' jiġi ġestit b'restrizzjonijiet u monitoraġġ regolari tal-fwied u jitqies aċċettabbli meta wieħed iqis ilgravità tal-kundizzjonijiet u n-nuqqas ta' kura.
English: Four studies involving 715 patients with Lennox-Gastaut or Dravet syndrome looked at the effect of Epidyolex when added to treatment with other epilepsy medicines.
Maltese: Erba' studji li fihom ħadu sehem 715-il pazjent bis-sindrome Lennox-Gnaut jew bis-sindrome Dravet ħarsu lejn l-effett ta' Epidyolex meta ġie miżjud ma' kura b'mediċini oħra tal-epilessija.
English: They showed that Epidyolex lowered the number of seizures after 14 weeks in patients who were also taking clobazam.
Maltese: Huma wrew li Epidyolex naqqas l-għadd ta' attakki wara 14-il ġimgħa f'pazjenti li kienu qed jieħdu clobazam ukoll.
English: Why is Epidyolex authorised in the EU?
Maltese: Għaliex Epidyolex ġie awtorizzat fl-UE?
English: As this is important for the transmission of electrical signals in some nerve cells, and seizures are caused by excessive electrical activity in the brain, altering the movement of calcium is expected to reduce or prevent the
Maltese: Peress li dan huwa importanti għat-trażmissjoni ta' sinjali elettriċi f'xi ċelluli tan-nervituri, u l-attakki epilettiċi huma kkawżati minn attività elettrika eċċessiva fil-moħħ, it-tibdil fil-moviment tal-kalċju huwa mistenni li jnaqqas jew jipprevjeni l-attakki epilettiċi f'pazjenti bis-sindrome ta' Lennox-Gastaut jew is-sindrome ta' Dravet.
English: The most common reason for stopping treatment was increased blood levels of liver enzymes (a sign of liver problems).
Maltese: Ir-raġuni l-aktar komuni biex titwaqqaf il-kura kienet iż-żieda fil-livelli tad-demm ta' enzimi tal-fwied (sinjal ta' problemi fil-fwied).
English: 180 (6 x 30) tablets (multipack)
Maltese: 180 (6 x 30) pillola (pakkett multiplu)
English: bottle (HDPE) (without outer carton)
Maltese: Flixkun (HDPE) (mingħajr kartuna ta' barra)
English: 90 sachets (with dosing spoon)
Maltese: 90 qartas (b'kuċċarina għad-dożaġġ)
English: For instructions for preparation see section 6.6.
Maltese: Għal istruzzjonijiet dwar il-preparazzjoni ara sezzjoni 6.6.
English: The active substance is pantoprazole.
Maltese: - Is-sustanza attiva hi pantoprazole.
English: HIV medications (atazanavir)
Maltese: Mediċini kontra l-HIV (atazanavir)
English: Core: sodium carbonate (anhydrous), mannitol, crospovidone, povidone K90, calcium stearate.
Maltese: Qalba: sodium carbonate (anhydrous), mannitol, crospovidone, povidone K90, calcium stearate.
English: Disturbances in vision / blurred vision
Maltese: Disturbi filvista/vista mċajpra
English: Coating: hypromellose, povidone K25, titanium dioxide (E171), yellow iron oxide (E172), propylene glycol, methacrylic acid-ethyl acrylate copolymer (1:1), polysorbate 80, sodium laurilsulfate, triethyl citrate.
Maltese: Kisja: hypromellose, povidone K25, titanium dioxide (E171), yellow iron oxide (E172), propylene glycol, methacrylic acid-ethyl acrylate copolymer (1:1), polysorbate 80, sodium laurilsulfate, triethyl citrate.
English: Body temperature increased;
Maltese: Żieda fittemperatura talġisem;
English: Printing ink: shellac, red, black and yellow iron oxide (E172), soya lecithin, titanium dioxide (E171) and antifoam DC 1510 (dimeticone emulsion).
Maltese: Linka tal-istampar: shellac, red, black and yellow iron oxide (E172), soya lecithin, titanium dioxide (E171) u antifoam DC 1510 (dimeticone emulsion).
English: The usual dose is:
Maltese: Id-doża normali hi:
English: Disodium edetate Sodium hydroxide (for pH adjustment)
Maltese: Disodium edetate Sodium hydroxide (għall-aġġustament tal-pH)
English: Gastro-resistant tablet (tablet).
Maltese: Pillola gastro-reżistenti (pillola).
English: Blister (ALU/ALU blister) with cardboard reinforcement (blister wallet).
Maltese: Folja (folja ALU/ALU) b'cardboard reinforcement (wallet bil-folji).
English: Controloc 40 mg prašek za raztopino za injiciranje Anagastra 40 mg polvo para solución inyectable I.V.
Maltese: Controloc 40 mg prašek za raztopino za injiciranje Anagastra 40 mg polvo para solución inyectable I.V. Pantoloc
English: Each vial contains 1 mg disodium edetate and 0.24 mg sodium hydroxide.
Maltese: Kull kunjett fih 1 mg ta' disodium edetate u 0.24 mg ta' sodium hydroxide.
English: Each gastro-resistant tablet contains 1.06 microgram soya oil.
Maltese: Kull pillola gastro-reżistenti fiha 1.06 mikrogrammi ta' żejt tas-sojja.
English: Lithuania Luxembourg Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain
Maltese: Il-Lussemburgu L-Olanda In-Norvegja Il-Polonja Il-Portugall Ir-Rumanija Is-Slovakkja Is-Slovenja Spanja
English: In presence of alarm symptoms
Maltese: Fil-preżenza ta' sintomi ta' allarm
English: Blister (ALU/ALU blister) without cardboard reinforcement.
Maltese: Folja (folja ALU/ALU) mingħajr cardboard reinforcement.
English: Adults and adolescents 12 years of age and above Symptomatic gastro-oesophageal reflux disease.
Maltese: Adulti u adoloxxenti minn 12-il sena 'l fuq Mard sintomatiku tar-rifluss gastro-esofagali.
English: Greece Hungary Ireland Italy
Maltese: Il-Greċja L-Ungerija L-Irlanda L-Italja
English: For gastric ulcers, duodenal ulcers and reflux oesophagitis.
Maltese: Għal ulċeri gastriċi, ulċeri duwodenali u esofagite riflussa.
English: AUC and volume of distribution were in accordance with data from adults.
Maltese: L-AUC u l-volum tad-distribuzzjoni kienu b'konformità ma' l-informazzoni mill-adulti.
English: Pack with 5 (5x1) vials.
Maltese: Pakkett b'5 (5x1) kunjetti.
English: Approximately 5 % of patients can be expected to experience adverse drug reactions (ADRs).
Maltese: Madwar 5% tal-pazjenti huma mistennija li jkollhom reazzjonijiet avversi tal-mediċina (ADRs).
English: The table below lists adverse reactions reported with pantoprazole, ranked under the following frequency classification:
Maltese: It-tabella t'hawn taħt telenka r-reazzjonijiet avversi rrappurtati bi pantoprazole, ikklassifikati taħt il-klassifikazzjoni tal-frekwenza li ġejja:
English: Volume of distribution is about 0.15 l/kg
Maltese: Il-volum tad-distribuzzjoni hu ta' madwar 0.15 l/kg
English: 28 gastro-resistant tablets 30 gastro-resistant tablets
Maltese: 28 pillola gastro-reżistenti 30 pillola gastro-reżistenti
English: Member State
Maltese: Membru
English: Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.
Maltese: Is-Sindrome ta' Zollinger-Ellison u kundizzjonijiet ipersekretorji patoloġiċi oħrajn.
English: Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment (see section 4.4).
Maltese: Prevenzjoni ta' ulċeri gastroduwodenali kkaġunati minn mediċini mhux sterojdi kontra l-infjammazzjoni (NSAIDs) mhux selettivi f'pazjenti f'riskju li jeħtieġu kura kontinwa bl-NSAID (ara sezzjoni 4.4).
English: twice daily one tablet Protium + twice daily 400 - 500 mg metronidazole (or 500 mg tinidazole) + twice daily 250 - 500 mg clarithromycin c) twice daily one tablet Protium + twice daily 1000 mg amoxicillin + twice daily 400 - 500 mg metronidazole (or 500 mg tinidazole)
Maltese: a) pillola Protium waħda darbtejn kuljum + amoxicillin 1000 mg darbtejn kuljum + clarithromycin 500 mg darbtejn kuljum b) pillola Protium waħda darbtejn kuljum + metronidazole 400 - 500 mg darbtejn kuljum (jew 500 mg ta' tinidazole) + clarithromycin 250 - 500 mg darbtejn kuljum ċ) pillola Protium waħda darbtejn kuljum + amoxicillin 1000 mg darbtejn kuljum + metronidazole 400 - 500 mg darbtejn kuljum (jew 500 mg ta' tinidazole)
English: In these individuals the metabolism of pantoprazole is probably mainly catalysed by CYP3A4.
Maltese: F'dawn l-individwi, il-metaboliżmu ta' pantoprazole hu probabbilment ikkatalizzat prinċipalment minn CYP3A4.
English: Results from a range of interaction studies demonstrate that pantoprazole does not effect the metabolism of active substances metabolised by CYP1A2 (such as caffeine, theophylline), CYP2C9 (such as piroxicam, diclofenac, naproxen), CYP2D6 (such as metoprolol), CYP2E1 (such as ethanol) or does not interfere with p-glycoprotein related absorption of digoxin.
Maltese: Ir-riżultati minn medda ta' studji dwar l-interazzjonijiet juru li pantoprazole ma jaffettwax il-metaboliżmu ta' sustanzi attivi metabolizzati minn CYP1A2 (bħal kaffeina, theophylline), CYP2C9 (bħal piroxicam, diclofenac, naproxen), CYP2D6 (bħal metoprolol), CYP2E1 (bħal ethanol) jew ma jinterferixxux mal-assorbiment ta' digoxin assoċjat ma' glikoproteina-p.
English: - Atazanavir (used to treat HIV-infection).
Maltese: - Atazanavir (jintuża għall-kura ta' infezzjoni bl-HIV).
English: Protium is available in the following pack sizes:
Maltese: Protium hu disponibbli fid-daqsijiet tal-pakkett li ġejjin:
English: Symptomatic gastro-oesophageal reflux disease
Maltese: Mard sintomatiku tar-rifluss gastro-esofagali
English: Packs: bottles (high density polyethylene container with low density polyethylene screw cap closure) and blister (ALU/ALU blister) without cardboard reinforcement or with cardboard reinforcement (blister wallet).
Maltese: Pakketti: fliexken (kontenitur tal-polyethylene ta' densità għolja li jingħalaq b'għatu bil-kamin tal-polyethylene ta' densità baxxa) u folja (folja ALU/ALU) mingħajr cardboard reinforcement jew b' cardboard reinforcement (wallet bil-folji).
English: Influence on vitamin B12 absorption
Maltese: Influwenza fuq l-assorbiment ta' vitamina
English: The treatment period for duodenal ulcers is usually between 2 and 4 weeks.
Maltese: Il-perjodu ta' kura għal ulċeri duwodenali hu normalment ta' bejn 2 u 4 ġimgħat.
English: Thrombocytopenia; Leukopenia
Maltese: Tromboċitopenja; Lewkopenja
English: Czech Republic Denmark Finland
Maltese: Id-Danimarka Il-Finlandja Franza
English: 98 (2x49) gastro-resistant tablets
Maltese: 98 (2x49) pillola gastro-reżistenti 100 pillola gastro-reżistenti
English: Special patient groups:
Maltese: Kategorija farmakoterapewtika:
English: Hospital packs: 1 vial, 5 (5x1) vials, 10 (10x1) vials and 20 (20x1) vials with powder for solution for injection.
Maltese: Pakketti tal-isptar: 1 kunjett, 5 (5x1) kunjetti, 10 (10x1) kunjetti u 20 (20x1) kunjett bi trab għal soluzzjoni għall-injezzjoni.
English: PHARMACOLOGICAL PROPERTIES
Maltese: Farmakokinetika Ġenerali
English: Pack with 7 gastro-resistant tablets.
Maltese: Pakkett b'7 pilloli gastro-reżistenti.